Pacira BioSciences, Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

22.33

-0.31 (-1.37%)

At close: Jun 18, 2026, 4:00 PM EDT

22.33

0.00 (0.01%)

After-hours: Jun 18, 2026, 4:24 PM EDT

Pacira BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	734.86	726.41	700.97	674.98	666.82	541.53
Revenue Growth (YoY)	4.57%	3.63%	3.85%	1.22%	23.14%	26.04%
Cost of Revenue	151.86	149.75	170.43	184.67	199.3	140.26
Gross Profit	583.01	576.66	530.54	490.31	467.53	401.28
Selling, General & Admin	375.93	368.76	294.1	269.44	254.52	199.35
Depreciation & Amortization Expenses	57.29	57.29	57.29	57.29	57.29	13.55
Research & Development	119.69	117.31	81.58	76.26	84.8	55.55
Other Operating Expenses	6	14.11	170.95	-0.35	10.9	42.91
Total Operating Expenses	558.91	557.47	603.91	402.63	407.5	311.35
Operating Income	24.1	19.19	-73.37	87.68	60.02	89.92
Interest Income	17.77	22.73	19.69	11.44	4.54	0.9
Interest Expense	-16.57	-17.45	-16.57	-20.31	-39.98	-31.75
Other Non-Operating Income (Expense)	-12.14	-7.6	7.15	-17.11	-11.29	-2.67
Total Non-Operating Income (Expense)	-10.94	-2.32	10.27	-25.97	-46.72	-33.52
Pretax Income	13.17	16.87	-63.11	61.7	13.3	56.4
Provision for Income Taxes	8.03	9.84	36.45	19.75	-2.61	14.42
Net Income	5.14	7.03	-99.56	41.96	15.91	41.98
Net Income to Common	5.14	7.03	-99.56	41.96	15.91	41.98
Net Income Growth	-	-	-	163.72%	-62.10%	-71.15%
Shares Outstanding (Basic)	43	45	46	46	46	44
Shares Outstanding (Diluted)	43	45	46	52	47	46
Shares Change (YoY)	-9.59%	-2.60%	-11.03%	11.69%	1.99%	4.46%
EPS (Basic)	0.12	0.16	-2.15	0.91	0.35	0.95
EPS (Diluted)	0.12	0.16	-2.15	0.89	0.34	0.92
EPS Growth	-	-	-	161.77%	-63.04%	-72.37%
Free Cash Flow	-	0	178.75	139.49	115.2	79.85
Free Cash Flow Growth	-	-	28.15%	21.09%	44.27%	103.54%
Free Cash Flow Per Share	-	-	3.87	2.68	2.48	1.75
Gross Margin	79.34%	79.39%	75.69%	72.64%	70.11%	74.10%
Operating Margin	3.28%	2.64%	-10.47%	12.99%	9.00%	16.61%
Profit Margin	0.70%	0.97%	-14.20%	6.22%	2.39%	7.75%
FCF Margin	-	0.00%	25.50%	20.67%	17.28%	14.75%
EBITDA	24.1	19.19	5.41	163.25	151.53	118.47
EBITDA Margin	3.28%	2.64%	0.77%	24.19%	22.72%	21.88%
EBIT	24.1	19.19	-73.37	87.68	60.02	89.92
EBIT Margin	3.28%	2.64%	-10.47%	12.99%	9.00%	16.61%
Effective Tax Rate	60.98%	58.31%	-57.77%	32.00%	-19.60%	25.57%

SEC Filings: 10-K · 10-Q